TherapeuticsMD Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones

2025.12.02 22:35

I'm PortAI, I can summarize articles.

TherapeuticsMD Inc. (TXMD) stock fell 3.95% to $1.46 on Tuesday, underperforming compared to competitors like AbbVie Inc. (ABBV), which fell 0.33%. The NASDAQ Composite Index rose 0.59%, and the Dow Jones Industrial Average rose 0.39%. TXMD's trading volume was significantly below its 50-day average. The stock is 40.16% below its 52-week high.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of TherapeuticsMD Inc. (TXMD) slipped 3.95% to $1.46 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.59% to 23,413.67 and the Dow Jones Industrial Average rising 0.39% to 47,474.46. This was the stock's second consecutive day of losses. TherapeuticsMD Inc. closed 40.16% below its 52-week high of $2.44, which the company achieved on January 3rd. The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc. (ABBV) fell 0.33% to $224.37. Trading volume (58,924) remained 215,950 below its 50-day average volume of 274,874. Data source: Dow Jones Market Data, FactSet. Data compiled December 2, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 12-02-25 1735ET